The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Our translational research program aims to leverage our expertise in genetic therapies and personalized medicine to develop clinical solutions that target the molecular causes of human diseases.
The Department of Genetic Medicine advances treatments and diagnostics through diverse clinical trials, including drug testing and research to better understand diseases.
Correction: Type 2 Diabetes Risk Allele Loci in the Qatari Population.
Publication Type
Erratum
Authors
O'Beirne S, Salit J, Rodriguez-Flores J, Staudt M, Abi Khalil C, Fakhro K, Robay A, Ramstetter M, Al-Azwani I, Malek J, Zirie M, Jayyousi A, Badii R, Al-Nabet Al-Marri A, Chiuchiolo M, Al-Shakaki A, Chidiac O, Gharbiah M, Bener A, Stadler D, Hackett N, Mezey J, Crystal R
Journal
PLoS One
Volume
11
Issue
8
Pagination
e0161910
Date Published
08/23/2016
ISSN
1932-6203
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0156834.].